Welcome to LookChem.com Sign In|Join Free

CAS

  • or
7-Keto-dehydroepiandrosterone is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

566-19-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 566-19-8 Structure
  • Basic information

    1. Product Name: 7-Keto-dehydroepiandrosterone
    2. Synonyms: DEHYDROEPIANDROSTERONE, 7-KETO;5-androstene-3b-ol-7,17-dione;5-ANDROSTEN-3-BETA-OL-7,17-DIONE;7-KETO-DEHYDROEPIANDROSTERONE;7-KETO DHEA;7-hydroxydehydroepiandrosterone;7-Oxo-dehydroepiandrosterone;androst-5-ene-7,17-dione,3beta-hydroxy
    3. CAS NO:566-19-8
    4. Molecular Formula: C19H26O3
    5. Molecular Weight: 302.41
    6. EINECS: 1592732-453-0
    7. Product Categories: Steroids & Hormones - 13C & 2H;Cnbio;steroids;Steroid and Hormone
    8. Mol File: 566-19-8.mol
  • Chemical Properties

    1. Melting Point: 245-248 °C
    2. Boiling Point: 477.1 °C at 760 mmHg
    3. Flash Point: 256.5 °C
    4. Appearance: /
    5. Density: 1.19 g/cm3
    6. Vapor Pressure: 4.15E-11mmHg at 25°C
    7. Refractive Index: 1.569
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 14.67±0.60(Predicted)
    11. CAS DataBase Reference: 7-Keto-dehydroepiandrosterone(CAS DataBase Reference)
    12. NIST Chemistry Reference: 7-Keto-dehydroepiandrosterone(566-19-8)
    13. EPA Substance Registry System: 7-Keto-dehydroepiandrosterone(566-19-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 566-19-8(Hazardous Substances Data)

566-19-8 Usage

Physiological effects

In the past ten years, a large number of studies have shown that 7-keto dehydroepiandrosterone has stronger physiological activity than DHEA, especially in anti-aging, enhancing immunity, improving memory, enhancing brain function, preventing Alzheimer’s and diabetes , It has a strong effect on reducing the risk of heart disease, losing weight, increasing bone density and muscle vitality.

Check Digit Verification of cas no

The CAS Registry Mumber 566-19-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,6 and 6 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 566-19:
(5*5)+(4*6)+(3*6)+(2*1)+(1*9)=78
78 % 10 = 8
So 566-19-8 is a valid CAS Registry Number.
InChI:InChI=1/C19H26O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h10,12-14,17,20H,3-9H2,1-2H3/t12-,13-,14-,17-,18-,19-/m0/s1

566-19-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Keto Dehydro Epiandrosterone

1.2 Other means of identification

Product number -
Other names 7-Keto-dehydroepiandrosterone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:566-19-8 SDS

566-19-8Synthetic route

dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With tert.-butylhydroperoxide; N-hydroxyphthalimide; cobalt(II) acetate In acetone at 20℃; for 5h; regioselective reaction;81.1%
With N-hydroxyphthalimide; sodium dichromate; chromium(III) perchlorate In acetone at 20℃; for 48h; Product distribution / selectivity;74.25%
With tert.-butylhydroperoxide; dirhodium(II) tetrakis(caprolactam) In water; 1,2-dichloro-ethane at 40℃; for 20h;74%
(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,3,4,8,9,10,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-17,2'-[1,3]dioxolan]-7(2H)-one
166173-97-3

(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,3,4,8,9,10,11,12,13,14,15,16-dodecahydrospiro[cyclopenta[a]phenanthrene-17,2'-[1,3]dioxolan]-7(2H)-one

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With perchloric acid; water In acetone at 20℃; for 20h;65%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

Conditions
ConditionsYield
With Mortierella isabellina AM212 fungal strain for 12h; Enzymatic reaction;A 6%
B 53.5%
C 24%
With Absidia coerulea AM93 In acetone at 20℃; for 8h; Time; Enzymatic reaction;A 5.5%
B 22%
C 49%
3β-hydroxy-17,17-ethylenedioxo-5-androstene
7745-40-6, 14456-21-4

3β-hydroxy-17,17-ethylenedioxo-5-androstene

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With CrO3/NHPI on activated clay In dichloromethane at 20℃;40%
prasterone acetate
853-23-6

prasterone acetate

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

D

3β,14α-dihydroxyandrost-5-en-7,17-dione
58211-52-2

3β,14α-dihydroxyandrost-5-en-7,17-dione

Conditions
ConditionsYield
With Cunninghamella elegans In ethanol for 72h; Further byproducts given;A 5.4%
B 26.8%
C 9%
D 1.1%
With Cunninghamella elegans In ethanol for 72h; Further byproducts given;A 5.4%
B 26.8%
C 9%
D 1.1%
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

D

3β,7β-dihydroxy-5β,6β-epoxyandrostan-17-one

3β,7β-dihydroxy-5β,6β-epoxyandrostan-17-one

E

3β,4β,7β-trihydroxyandrost-5-en-17-one

3β,4β,7β-trihydroxyandrost-5-en-17-one

F

3β,7α-dihydroxy-5β,6β-epoxyandrostan-17-one

3β,7α-dihydroxy-5β,6β-epoxyandrostan-17-one

G

3β,4β,7α-trihydroxyandrost-5-en-17-one

3β,4β,7α-trihydroxyandrost-5-en-17-one

Conditions
ConditionsYield
With Ulocladium chartarum MRC 72584 In water; N,N-dimethyl-formamide at 28℃; for 120h; Enzymatic reaction;A 6%
B 12%
C 16%
D 3%
E 4%
F 2%
G 3%
prasterone acetate
853-23-6

prasterone acetate

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

C

5,6β-epoxy-3β,12α-dihydroxy-5β-androstan-17-one
58324-06-4

5,6β-epoxy-3β,12α-dihydroxy-5β-androstan-17-one

D

3β,14α-dihydroxyandrost-5-en-7,17-dione
58211-52-2

3β,14α-dihydroxyandrost-5-en-7,17-dione

Conditions
ConditionsYield
With Cunninghamella elegans In ethanol for 72h; Further byproducts given;A 5.4%
B 9%
C 4.1%
D 1.1%
prasterone acetate
853-23-6

prasterone acetate

di-tert-butyl chromate
1189-85-1

di-tert-butyl chromate

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
und anschliessend Hydrolysieren;
prasterone acetate
853-23-6

prasterone acetate

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With chromium(VI) oxide und anschliessend Hydrolysieren;
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With sodium carbonate In methanol
With sodium hydrogencarbonate In methanol307 mg
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

B

3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

C

Androst-5-ene-3beta,7alpha,17beta-triol
2697-85-0, 62357-04-4, 2226-66-6

Androst-5-ene-3beta,7alpha,17beta-triol

Conditions
ConditionsYield
With fungus Fusarium oxysporum var. cubense In ethanol at 27℃; Product distribution; biotransformation; Microbiological reaction; fungus Fusarium oxysporum var. cubense (from rhizome of banana plant showing symptoms of Panama disease);
With fungus Fusarium oxysporum In ethanol at 27℃; for 180h; biotransformation; Title compound not separated from byproducts;
7-oxo-dehydroepiandrosterone-3β-sulfate

7-oxo-dehydroepiandrosterone-3β-sulfate

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With perchloric acid In ethyl acetate at 25℃; for 0.25h;99.5 % Chromat.
5-androsten-7,17-dione-3β-ol ethylene ketal tert-butyldimethylsilyl ether
202415-77-8

5-androsten-7,17-dione-3β-ol ethylene ketal tert-butyldimethylsilyl ether

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With hydrogenchloride In tetrahydrofuran; methanol
prasterone acetate
853-23-6

prasterone acetate

KMnO4

KMnO4

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 72 percent / N-hydroxyphthalimide, azobis(cyclohexane-carbonitrile), air / acetone; ethyl acetate / 9 h / Heating
2: Na2CO3 / methanol
View Scheme
3β,7α-dihydroxyandrost-5-ene-17-one
2487-48-1, 7522-54-5, 62357-03-3, 53-00-9

3β,7α-dihydroxyandrost-5-ene-17-one

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With polyoxyethylenesorbitan monooleate; soy protein, hydrolyzed; dipotassium hydrogenphosphate; potassium dihydrogenphosphate; yiest; autolysed extract of In water for 144h; Enzymatic reaction;
With Mortierella isabellina AM212 fungal strain for 12h; Enzymatic reaction;9.7 %Chromat.
5-androsten-3β,7β-diol-17-one
2487-48-1

5-androsten-3β,7β-diol-17-one

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With Mortierella isabellina AM212 fungal strain for 12h; Enzymatic reaction;32 %Chromat.
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

acetic anhydride
108-24-7

acetic anhydride

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Conditions
ConditionsYield
With toluene-4-sulfonic acid for 0.0333333h; microwave irradiation;96%
for 3h; Reflux;85%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(3β)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]androst-5-ene-7,17-dione
157302-54-0

(3β)-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]androst-5-ene-7,17-dione

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 3h;92.6%
With 1H-imidazole
1H-imidazole
288-32-4

1H-imidazole

to-butyldimethysilyl chloride

to-butyldimethysilyl chloride

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

3β-t-butyldimethylsilyloxyandrost-5-ene-7,17-dione

3β-t-butyldimethylsilyloxyandrost-5-ene-7,17-dione

Conditions
ConditionsYield
In N-methyl-acetamide92.6%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

3β-carboethoxyandrost-5-ene-7,17-dione

3β-carboethoxyandrost-5-ene-7,17-dione

Conditions
ConditionsYield
In pyridine at 0 - 5℃;90%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

3β-carboethoxyandrost-5-ene-7,17-dione

3β-carboethoxyandrost-5-ene-7,17-dione

Conditions
ConditionsYield
In pyridine90%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

5-androstene-3β,7β,17β-triol
2697-85-0

5-androstene-3β,7β,17β-triol

Conditions
ConditionsYield
With sodium tetrahydroborate; cerium(III) chloride In methanol; dichloromethane at 0 - 5℃; for 0.5h; pH=15;88%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

androsta-3,5-diene-7,17-dione
1420-49-1

androsta-3,5-diene-7,17-dione

Conditions
ConditionsYield
With perchloric acid In methanol; water at 20℃; for 12h;80%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

C21H20Cl5NO3

C21H20Cl5NO3

androst-5-en-7,17-dione-3β-yl 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoate
1454311-30-8

androst-5-en-7,17-dione-3β-yl 2-[4-N,N-bis(2-chloroethyl)amino-phenyl]butanoate

Conditions
ConditionsYield
With dmap In toluene for 1.5h; Inert atmosphere; Reflux;80%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

isobutyl chloroformate
543-27-1

isobutyl chloroformate

3β-carboiso-butoxyandrost-5-ene-7,17-dione

3β-carboiso-butoxyandrost-5-ene-7,17-dione

Conditions
ConditionsYield
In pyridine at 0 - 5℃;78%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

3β-hydroxy-5,17-dioxo-5,7-seco-B-norandrost-7-oic acid

3β-hydroxy-5,17-dioxo-5,7-seco-B-norandrost-7-oic acid

Conditions
ConditionsYield
With potassium permanganate; sodium periodate; potassium carbonate In water; tert-butyl alcohol at 60℃; for 2.33333h;78%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Allyl chloroformate
2937-50-0

Allyl chloroformate

3β-carboallyloxyandrost-5-ene-7,17-dione

3β-carboallyloxyandrost-5-ene-7,17-dione

Conditions
ConditionsYield
In tetrahydrofuran-pyridine78%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

isobutyl chloroformate
543-27-1

isobutyl chloroformate

3β-carboisobutoxyandrost-5-ene-7,17-dione

3β-carboisobutoxyandrost-5-ene-7,17-dione

Conditions
ConditionsYield
In pyridine78%
3,4-dihydro-2H-pyran
110-87-2

3,4-dihydro-2H-pyran

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

A

3β-(2-tetrahydropyranyloxy)-androst-5-ene-7,17-dione
102890-86-8

3β-(2-tetrahydropyranyloxy)-androst-5-ene-7,17-dione

B

androsta-3,5-diene-7,17-dione
1420-49-1

androsta-3,5-diene-7,17-dione

Conditions
ConditionsYield
With pyridinium p-toluenesulfonate In dichloromethane at 20℃; for 3h;A 68%
B 0.150 g
octyl chloroformate
7452-59-7

octyl chloroformate

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

3β-carbooctyloxyandrost-5-ene-7,17-dione

3β-carbooctyloxyandrost-5-ene-7,17-dione

Conditions
ConditionsYield
In pyridine at 0 - 5℃;65%
octyl chloroformate
7452-59-7

octyl chloroformate

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

3β-carbooctyloxyandrost-5-ene-7,17-dione
1056899-12-7

3β-carbooctyloxyandrost-5-ene-7,17-dione

Conditions
ConditionsYield
In pyridine65%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

(fluorenylmethoxy)carbonyl chloride
28920-43-6

(fluorenylmethoxy)carbonyl chloride

3β-carbo(9-fluorenyl)methoxyandrost-5-ene-7,17-dione

3β-carbo(9-fluorenyl)methoxyandrost-5-ene-7,17-dione

Conditions
ConditionsYield
In pyridine at 20℃; for 1h;57%
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

androst-5-ene-3,7,17-trione

androst-5-ene-3,7,17-trione

Conditions
ConditionsYield
With cyclohexanone; aluminum isopropoxide; toluene
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

p-toluenesulfonyl chloride
98-59-9

p-toluenesulfonyl chloride

3β-Tosyloxy-androsten-(5)-dion-(7,17)
897039-72-4

3β-Tosyloxy-androsten-(5)-dion-(7,17)

Conditions
ConditionsYield
With pyridine
5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

(3aS,4R,5S,7aS)-5-((1R,4S)-4-Hydroxy-1-methyl-2-oxo-cyclohexyl)-7a-methyl-1-oxo-octahydro-indene-4-carboxylic acid methyl ester

(3aS,4R,5S,7aS)-5-((1R,4S)-4-Hydroxy-1-methyl-2-oxo-cyclohexyl)-7a-methyl-1-oxo-octahydro-indene-4-carboxylic acid methyl ester

Conditions
ConditionsYield
(i) aq. H2O2, KOH, MeOH, (ii) /BRN= 102415/; Multistep reaction;
butanoic acid anhydride
106-31-0

butanoic acid anhydride

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Butyric acid (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7,17-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Butyric acid (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7,17-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With pyridine
n-dodecanoyl chloride
112-16-3

n-dodecanoyl chloride

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Dodecanoic acid (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7,17-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Dodecanoic acid (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7,17-dioxo-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With pyridine

566-19-8Relevant articles and documents

Microbial transformation of dehydroepiandrosterone (DHEA) by some fungi

Yildirim, Kudret,Kuru, Ali,Y?lmazer Keskin, Semra,Ergin, Sinan

, p. 465 - 474 (2020/11/12)

In this work, biotransformations of dehydroepiandrosterone (DHEA) 1 by Ulocladium chartarum MRC 72584, Cladosporium sphaerospermum MRC 70266 and Cladosporium cladosporioides MRC 70282 have been reported. U. chartarum MRC 72584 mainly hydroxylated 1 at C-7α and C-7β, accompanied by a minor hydroxylation at C-4β, a minor epoxidation from the β-face and a minor oxidation at C-7 subsequent to its hydroxylations. 3β,7β-Dihydroxy-5β,6β-epoxyandrostan-17-one 6, 3β,4β,7α-trihydroxyandrost-5-en-17-one 7 and 3β,4β,7β-trihydroxyandrost-5-en-17-one 8 from this incubation were identified as new metabolites. C. sphaerospermum MRC 70266 converted some of 1 into a 3-keto-4-ene steroid and then hydroxylated at C-6α, C-6β and C-7α, accompanied a minor 5α-reduction and a minor oxidation at C-6 following its hydroxylations. C. sphaerospermum MRC 70266 also hydroxylated some of 1 at C-7α and C-7β. C. cladosporioides MRC 70282 converted almost half of 1 into a 3-keto-4-ene steroid and then hydroxylated at C-6α and C-6β. C. cladosporioides MRC 70282 also reduced some of 1 at C-17.

Metal-Free Allylic Oxidation of Steroids Using TBAI/TBHP Organocatalytic Protocol

Lam, Ying-Pong,Yeung, Ying-Yeung

supporting information, p. 2369 - 2372 (2018/04/19)

A mild, efficient and organocatalytic allylic oxidation of steroids using a TBAI/TBHP protocol has been developed. A range of bioactive Δ5-en-7-ones can be easily prepared from the corresponding Δ5-steroids. The methodology features several advantages, including readily available starting materials, environmentally benign oxidant, high functional group compatibility, and metal-free catalysis.

Scalable and sustainable electrochemical allylic C-H oxidation

Horn, Evan J.,Rosen, Brandon R.,Chen, Yong,Tang, Jiaze,Chen, Ke,Eastgate, Martin D.,Baran, Phil S.

, p. 77 - 81 (2016/06/01)

New methods and strategies for the direct functionalization of C-H bonds are beginning to reshape the field of retrosynthetic analysis, affecting the synthesis of natural products, medicines and materials. The oxidation of allylic systems has played a prominent role in this context as possibly the most widely applied C-H functionalization, owing to the utility of enones and allylic alcohols as versatile intermediates, and their prevalence in natural and unnatural materials. Allylic oxidations have featured in hundreds of syntheses, including some natural product syntheses regarded as € classics €. Despite many attempts to improve the efficiency and practicality of this transformation, the majority of conditions still use highly toxic reagents (based around toxic elements such as chromium or selenium) or expensive catalysts (such as palladium or rhodium). These requirements are problematic in industrial settings; currently, no scalable and sustainable solution to allylic oxidation exists. This oxidation strategy is therefore rarely used for large-scale synthetic applications, limiting the adoption of this retrosynthetic strategy by industrial scientists. Here we describe an electrochemical C-H oxidation strategy that exhibits broad substrate scope, operational simplicity and high chemoselectivity. It uses inexpensive and readily available materials, and represents a scalable allylic C-H oxidation (demonstrated on 100 grams), enabling the adoption of this C-H oxidation strategy in large-scale industrial settings without substantial environmental impact.

Biohydroxylation of 7-oxo-DHEA, a natural metabolite of DHEA, resulting in formation of new metabolites of potential pharmaceutical interest

?wizdor, Alina,Panek, Anna,Milecka-Tronina, Natalia

, p. 844 - 849 (2016/11/11)

Metabolism of steroids in healthy and unhealthy human organs is the subject of extensive clinical and biomedical studies. For this kind of investigations, it is essential that the reference samples of new derivatives of natural, physiologically active steroids (especially those difficult to achieve in the chemical synthesis) become available. This study demonstrated for the first time transformation of 7-oxo-DHEA—a natural metabolite of DHEA, using Syncephalastrum racemosum cells. The single-pulse fermentation of substrate produced two new hydroxy metabolites: 1β,3β-dihydroxy-androst-5-en-7,17-dione and 3β,12β-dihydroxy-androst-5-en-7,17-dione, along with the earlier reported 3β,9α-dihydroxy-androst-5-en-7,17-dione and 3β,17β-dihydroxy-androst-5-en-7-one. Simultaneously, the same metabolites, together with small quantities of 7α- and 7β-hydroxy-DHEA, as well as the products of their reduction at the C-17 were obtained after transformation of DHEA under pulse-feeding of the substrate. The observed reactions suggested that this micro-organism contains enzymes exhibiting similar activity to those present in human cells. Thus, the resulting compounds can be considered as potential components of the eukaryotic, including human, metabolome.

N-Hydroxyphthalimide catalyzed allylic oxidation of steroids with t-butyl hydroperoxide

Zhao, Qian,Qian, Chao,Chen, Xin-Zhi

, p. 1 - 6 (2015/02/19)

A new and optimized procedure for the allylic oxidation of Δ5-steroids with t-butyl hydroperoxide in the presence of catalytic amounts of N-hydroxyphthalimide (NHPI) under mild conditions was developed, showing excellent regioselectivity and chemoselectivity (functional group compatibility). It was found that Co(OAc)2 could enhance the catalytic ability of NHPI resulting in better yields and shorter reaction times. The reaction mechanism and the scope of the reaction with a variety of Δ5-steroidal substrates were also investigated.

Allylic oxidation of steroidal olefins by vanadyl acetylacetonate and tert-butyl hydroperoxide

Grainger, Wendell S.,Parish, Edward J.

, p. 103 - 109 (2015/06/30)

Abstract Readily available vanadyl acetylacetonate was found to oxidize the allylic sites of Δ5 steroidal alcohols without protection of hydroxyl groups. Cholesterol, dehydroepiandrosterone, cholesterol benzoate, cholesterol acetate, pregnenolone, and 5-pregnen-3,20-diene were oxidized to 7-keto products using vanadyl acetylacetonate in one pot reactions at room temperature in the presence of oxygen and water.

Hydroxylation of DHEA and its analogues by Absidia coerulea AM93. Can an inducible microbial hydroxylase catalyze 7α- and 7β-hydroxylation of 5-ene and 5α-dihydro C19-steroids?

Milecka-Tronina, Natalia,Ko?ek, Teresa,?wizdor, Alina,Panek, Anna

, p. 883 - 891 (2014/01/23)

In this paper we focus on the course of 7-hydroxylation of DHEA, androstenediol, epiandrosterone, and 5α-androstan-3,17-dione by Absidia coerulea AM93. Apart from that, we present a tentative analysis of the hydroxylation of steroids in A. coerulea AM93. DHEA and androstenediol were transformed to the mixture of allyl 7-hydroxy derivatives, while EpiA and 5α-androstan-3,17-dione were converted mainly to 7α- and 7β-alcohols accompanied by 9α- and 11α-hydroxy derivatives. On the basis of (i) time course analysis of hydroxylation of the abovementioned substrates, (ii) biotransformation with resting cells at different pH, (iii) enzyme inhibition analysis together with (iv) geometrical relationship between the C-H bond of the substrate undergoing hydroxylation and the cofactor-bound activated oxygen atom, it is postulated that the same enzyme can catalyze the oxidation of C7-Hα as well as C7-H β bonds in 5-ene and 5α-dihydro C19-steroids. Correlations observed between the structure of the substrate and the regioselectivity of hydroxylation suggest that 7β-hydroxylation may occur in the normal binding enzyme-substrate complex, while 7α-hydroxylation - in the reverse inverted binding complex.

Hydroxylation of DHEA, androstenediol and epiandrosterone by Mortierella isabellina AM212. Evidence indicating that both constitutive and inducible hydroxylases catalyze 7α- as well as 7β-hydroxylations of 5-ene substrates

Kolek, Teresa,Milecka, Natalia,Swizdor, Alina,Panek, Anna,Bialonska, Agata

, p. 5414 - 5422 (2011/09/13)

The course of transformation of DHEA, androstenediol and epiandrosterone in Mortierella isabellina AM212 culture was investigated. The mentioned substrates underwent effective hydroxylation; 5-ene substrates - DHEA and androstenediol - were transformed into a mixture of 7α- and 7β- allyl alcohols, while epiandrosterone was converted into 7α- (mainly), 11α- and 9α- monohydroxy derivatives. Ketoconazole and cycloheximide inhibition studies suggest the presence of constitutive and substrate-induced hydroxylases in M. isabellina. On the basis of time course analysis of the hydroxylation of DHEA and androstenediol, the oxidation of allyl C7-Hα and C7-Hβ bonds by the same enzyme is a reasonable assumption.

CrO3/NHPI adsorbed on activated clay: A new supported reagent for allylic selective oxidation of Δ5-sterols

Liu, Jin,Zhu, Hong-You,Cheng, Xiao-Hong

experimental part, p. 1076 - 1083 (2009/09/06)

Chromium trioxide and N-hydroxyphthalimide (NHPI) supported on activated clay could serve as an efficient and mild oxidant for allylic selective oxidation of Δ5-sterols. Thus, a ketone group could be easily introduced into the allylic position of Δ5-sterols with the existence of a sensitive 3β-hydroxyl group. The oxidant residue can be removed easily from the reaction mixture by filtration and reused after reactivation at 120δC for 4-6 h. Copyright Taylor & Francis Group, LLC.

Optimal TBHP allylic oxidation of Δ5 - Steroids catalyzed by dirhodium caprolactamate

Choi, Hojae,Doyle, Michael P.

, p. 5349 - 5352 (2008/09/17)

Dirhodium caprolactamate is the most efficient catalyst for the oxidation of Δ5-steroids to 7-keto-Δ5-steroids by 70% tert-butyl hydroperoxide in water (T-HYDRO). Isolated product yields range from 38 to 87%.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 566-19-8